Product Center

Product Center

Products Center

Prescription

OTC

Product Research

Medication Consultation

Fourth Mount Tai Medical Forum Concludes Jiuhua Huayuan Pharmaceutical Secures Four Prestigious Honors

2025-11-18

Jiuhua Huayuan Pharmaceutical's Class 1.1 innovative traditional Chinese medicine, Tongqiao Jingxuan Granules, has obtained clinical approval

2025-09-03

2025

I. The company has been approved to establish a national level postdoctoral research workstation

II. The company's drug surveillance work was commended by the National Center

2025-08-01

Official signing | Jiuhua Huayuan and Fudan School of Pharmacy jointly embark on a new journey of innovative research and development

2025-06-28

Bairui Granules appeared at the 27th Academic Annual Meeting of the Pulmonary Disease Branch of the Chinese Association of Traditional Chinese Medicine

2025-06-17

Jiuhua Huayuan Pharmaceutical made its debut at the 42nd Annual Conference of Traditional Chinese Medicine in China

2025-05-21

The Shenzhen Children's Respiratory Academic Exchange City Conference was successfully held

2025-05-21

Jiuhua Huayuan Pharmaceutical Chairman Guan Yueqin was awarded national recognition

2025-05-07

Jiuhua Huayuan Pharmaceutical's drug surveillance work has been awarded national recognition

2025-03-26

Jiuhua Huayuan Pharmaceutical was approved to set up a national postdoctoral research station

2025-03-07

< 1234...9 > proceed page